Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Apsis Group AB in its acquisition of Innometrics AB
Mandate

Vinge advises Apsis Group AB in its acquisition of Innometrics AB

June 22, 2016

Vinge advises Apsis Group AB in connection with its acquisition of Innometrics AB. Innometrics develops and sells data-driven digital marketing services allowing the customer to merge data from various sources, which is an area that Apsis, with its focus on email and marketing automation, has also focused on.

Vinge’s team consisted of partners Henrik Borna and Anna Edström, counsel Christian Lindhé and, among others, associates Emelie Svensäter Jerntorp, Mattias Sköld and Fredrik Lasson.

Related

Vinge advises Aspo on its acquisition of Swed Handling

 Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

 Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

 Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024